innoscripta SE
innoscripta SE provides software-as-a-service for managing research and development (R&D) tax incentives and project management consulting in Germany. It offers solutions for research and development documentation, such as human resources, task management, organization, project management, and time tracking. It serves the additive manufacturing/3D printing; aerospace engineering; automotive ; bio… Read more
innoscripta SE (1INN) - Total Liabilities
Latest total liabilities as of December 2025: €47.23 Million EUR
Based on the latest financial reports, innoscripta SE (1INN) has total liabilities worth €47.23 Million EUR as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
innoscripta SE - Total Liabilities Trend (2022–2025)
This chart illustrates how innoscripta SE's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
innoscripta SE Competitors by Total Liabilities
The table below lists competitors of innoscripta SE ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Cogstate Ltd
AU:CGS
|
Australia | AU$16.88 Million |
|
Stereotaxis Inc
NYSE MKT:STXS
|
USA | $34.05 Million |
|
WHA Utilities and Power Public Company Limited
BK:WHAUP
|
Thailand | ฿17.90 Billion |
|
Bank Yudha Bhakti Tbk
JK:BBYB
|
Indonesia | Rp14.07 Trillion |
|
Don Muang Tollway Public Company Limited
BK:DMT
|
Thailand | ฿804.87 Million |
|
TPI Polene Power Public Company Limited
BK:TPIPP
|
Thailand | ฿32.41 Billion |
|
FFB Bancorp
OTCQX:FFBB
|
USA | $1.40 Billion |
|
UmweltBank AG
XETRA:UBK
|
Germany | €-417.13 Million |
Liability Composition Analysis (2022–2025)
This chart breaks down innoscripta SE's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 10.32 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.88 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.47 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how innoscripta SE's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for innoscripta SE (2022–2025)
The table below shows the annual total liabilities of innoscripta SE from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €47.23 Million | +99.58% |
| 2024-12-31 | €23.66 Million | +36.66% |
| 2023-12-31 | €17.32 Million | -0.13% |
| 2022-12-31 | €17.34 Million | -- |